Daily Bulletin

Men's Weekly

.

Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union

PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to...

Read more: Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of...

Business News

Why Heavy Duty Moving Dollies Are Essential for Safe Transport in Australia

Moving heavy or bulky items can be challenging, especially when it involves transporting goods across warehouses, offices, or even during residential relocations. In Australia, where industries like c...

Daily Bulletin - avatar Daily Bulletin

Westlink Construction Cleaning Revolutionizes Warehouse Cleanliness with Eco-Friendly Solutions in Sydney

“Innovative cleaning services offer sustainable and efficient solutions to meet the growing demand for eco-conscious warehouse maintenance.” Westlink Construction Cleaning is proud to announce its gr...

Daily Bulletin - avatar Daily Bulletin

How HZad Education Supports International Students Preparing for CELPIP in Australia

As Australia officially accepts CELPIP (Canadian English Language Proficiency Index Program) for visa applications, international students face new opportunities alongside unprecedented preparation ch...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals